Dr. Collins et Sn. Davies, ARACHIDONIC-ACID METABOLITES AND THE SYNAPTIC POTENTIATION EVOKED BY ACTIVATION OF METABOTROPIC GLUTAMATE RECEPTORS, European journal of pharmacology, 342(2-3), 1998, pp. 213-216
We have previously shown that coapplication of arachidonic acid (10 mu
M) and (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (ACPD, 50 mu
M) evokes an enhancement of synaptic transmission in the CA1 region o
f the rat hippocampal slice. Here we have investigated whether the met
abolites of arachidonic acid are implicated in this potentiation. Incl
usion of the cyclo-oxygenase inhibitor indomethacin (10 mu M) did not
block the potentiation induced by coapplication of arachidonic acid an
d ACPD. However the presence of either the cyclo-, lipo- and epoxygena
se inhibitor 5,8,11,14-eicosatetraynoic acid (ETYA, 20 mu M), or the l
ipoxygenase inhibitor nordihydroguaiaretic acid (10 mu M), prevented t
he long-lasting enhancement. The results suggest that the lipoxygenase
and epoxygenase metabolites of arachidonic acid may be involved in th
e induction of this form of synaptic potentiation. (C) 1998 Elsevier S
cience B.V.